Last reviewed · How we verify

NCT03825471

Cranial Electrotherapy Stimulation on Anesthetics Consumption and Postoperative Pain

Status unknown NA Last updated 11 March 2020
What this trial tests

NA trial testing electrotherapy in Opioid Use in 80 participants. Status unknown.

Timeline
14 January 2019
Primary endpoint
31 December 2020
31 December 2020

Quick facts

Lead sponsorTri-Service General Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date14 January 2019
Primary completion31 December 2020
Estimated completion31 December 2020
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Tri-Service General Hospital

Who can join

Adults 20 to 80, any sex, with Opioid Use or Cytokine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cranial electrotherapy stimulation (CES) is a non-invasive intervention to treat anxiety, depression, insomnia, and pain. But clinical studies and applications of CES in relation to acute postoperative pain are few. tThe investigators investigate a double-blind, randomized controlled trial to figure out if intraoperative CES could decrease dosage of intraoperative anesthetics and patient-controlled analgesia (PCA) consumption in patients undergoing colon cancer surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of electrotherapy

Trials testing the same drug.

Other recruiting trials for Opioid Use

Currently open trials in the same condition.

Other Tri-Service General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03825471.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing